Showing results (1531-1540 of 3,965) with videos related to

Sort By:
Pageof 397
Translational Cancer Research|February 4, 2022
High pretreatment plasma D-dimer levels predict poor survival in patients with diffuse large B-cell lymphoma in the real worldHaobo Huang, Liping Fan, Danhui Fu, et al.
Translational Cancer Research|February 4, 2022
Integrative bioinformatics analysis identifies LINC01614 as a potential prognostic signature in esophageal cancerShuo Yan, Jichong Xu, Bingyan Liu, et al.
Translational Cancer Research|February 4, 2022
The value of combined detection of CEA, CYFRA21-1, SCC-Ag, and pro-GRP in the differential diagnosis of lung cancerJiezhou Li, Yangqing Chen, Xiandao Wang, et al.
Translational Cancer Research|February 4, 2022
Predicting factors of tumor progression in adult patients with low-grade glioma within five years after surgeryXuezheng Li, Ruimin Li, Hongbo Ren, et al.
Translational Cancer Research|February 4, 2022
Bleeding with gastrointestinal and ureteral ulcers after gefitinib treatment: a case reportJian Xiao, Wenjing Ruan, Ning Li, et al.
Translational Cancer Research|February 4, 2022
Characteristics of esophageal cancer in patients with head and neck squamous cell carcinomaLei Wang, Wenjing Pang, Kun Zhou, et al.
Translational Cancer Research|March 9, 2022
Preoperative blood testing for glioblastoma, brain metastases, and primary central nervous system lymphoma differentiationSong-Quan Wang, Qing Yuan, Guang-Tao Zhang, et al.
Translational Cancer Research|March 9, 2022
Knockdown of EphB3 inhibits cell proliferation partly through the AKT signaling pathway and represses epithelial-mesenchymal transition in esophageal squamous cell carcinomaLuqun Tang, Lijun Wang, Tao Yu, et al.
Translational Cancer Research|March 9, 2022
Patient-derived tumor spheroid cultures as a promising tool to assist personalized therapeutic decisions in breast cancerSarah Hofmann, Raichel Cohen-Harazi, Yael Maizels, et al.
Translational Cancer Research|March 9, 2022
Assessment of POLE and POLD1 mutations as prognosis and immunotherapy biomarkers for stomach adenocarcinomaMingyu Zhu, Haiyan Cui, Lu Zhang, et al.
Pageof 397